Rainbow Children’s Hospitals: Appoints Anshuman Jaiswal as Chief Legal Officer

Rainbow Children’s Hospitals announced the elevation of Mr. Anshuman Jaiswal to the position of Chief Legal Officer. The Board of Directors approved this appointment during their meeting held on July 30, 2026. Mr. Jaiswal, previously the Group Head – Legal, has also been designated as a Senior Management Personnel (SMP), effective immediately.

Key Leadership Appointment

Rainbow Children’s Medicare Limited has made a significant leadership announcement following its Board of Directors meeting on July 30, 2026. The company has approved the elevation of Mr. Anshuman Jaiswal from his role as Group Head – Legal to the esteemed position of Chief Legal Officer.

Designation as Senior Management Personnel

In addition to his new role as Chief Legal Officer, the Board has also designated Mr. Jaiswal as a Senior Management Personnel (SMP) of the Company. This designation is effective immediately and aligns with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This move underscores the company’s commitment to strengthening its legal and corporate governance framework.

Anshuman Jaiswal’s Profile

Mr. Jaiswal brings over two decades of experience as an India-qualified corporate counsel, having worked with prominent law firms and in-house. He is a graduate of NALSAR University of Law, Hyderabad, and has held significant positions at firms like Amarchand Mangaldas and Cyril Amarchand Mangaldas, as well as serving as Senior Vice President at GIC-controlled Greenko Group. His expertise spans strategic investments, capital markets, financing, corporate advisory, and commercial contracting.

Financial Results Review

The Board meeting also reviewed and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. These results, along with the limited review report from statutory auditors M/s. S.R. Batliboi & Associates LLP, have been enclosed as Annexure – A.

Source: BSE

Previous Article

Gillette India: New Executive Director Appointed; DIN Allotted

Next Article

Dhanuka Agritech: Clarifies Stock Appreciation Rights Plan 2026 Methodology